Literature DB >> 217290

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

W B Kannel, W P Castelli, T Gordon.   

Abstract

Prospective data at Framingham and elsewhere have shown conclusively that risk of coronary heart disease in persons younger than age 50 is strikingly related to the serum total cholesterol level. Within so-called normal limits risk has been found to mount over a five-fold range. The impact has been found to be augmented by other risk factors. The contribution of the serum total cholesterol to risk has also been found to be determined by its partition in the various lipoprotein fractions. A relatively large amount of cholesterol in the low-density lipoprotein fraction is atherogenic, whereas that in the high-density fraction appears protective. The independent contribution of very-low density lipoprotein and its triglyceride or cholesterol content has, on the other hand, not been established. The previous position that virtually all of the lipid information pertaining to coronary heart disease resided in the serum total cholesterol must be accordingly modified.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217290     DOI: 10.7326/0003-4819-90-1-85

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  195 in total

1.  The association between occupational lead exposure and serum cholesterol and lipoprotein levels.

Authors:  E Kristal-Boneh; D Coller; P Froom; G Harari; J Ribak
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.

Authors:  A D Sniderman; J Bergeron; J Frohlich
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

Review 3.  New developments in atherosclerosis imaging: electron beam tomography.

Authors:  H S Hecht
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

4.  Cardiovascular disease: risk factors in older Canadians.

Authors:  D R MacLean
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

Review 5.  Evidence based cardiology: emerging approaches in preventing cardiovascular disease.

Authors:  E M Lonn; S Yusuf
Journal:  BMJ       Date:  1999-05-15

Review 6.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

7.  Lipid screening in family practice: a critical appraisal of recent evidence.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

8.  Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.

Authors:  B G Jacob; W Möhrle; W O Richter; P Schwandt
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 9.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

Authors:  B H Chung; J P Segrest; K Smith; F M Griffin; C G Brouillette
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.